sevelamer

Known as: Sevelamero, poly(allylamine-co-N,N'-diallyl-1,3-diamino-2-hydroxypropane), Sevelamer [Chemical/Ingredient] 
A non-absorbable polymeric amine and phosphate binding agent that can be used to prevent hyperphosphatemia. Upon oral administration, the amine… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Stroke causes extensive cellular loss that leads to a disintegration of the afflicted brain tissue. Although transplanted neural… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND Previous clinical trials showed that progression of coronary artery calcification (CAC) may be slower in hemodialysis… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Elevated serum phosphorus and calcium are associated with arterial calcification and mortality in dialysis patients. Unlike… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Coronary artery calcification is more prevalent in dialysis patients than in patients without kidney disease and this is… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
The risk of death in hemodialysis patients treated with calcium-containing phosphate binders or sevelamer is not known. We… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND The novel phosphate binder sevelamer has been shown to prevent the progression of aortic and coronary calcification in… (More)
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND Calcium-based phosphate binders may induce tissue calcification, and little is known about their effects on bone… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2005
2005
OBJECTIVE Gout affects a large fraction of persons with advanced chronic kidney disease, and hyperuricemia may increase the risk… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND Cardiovascular disease is frequent and severe in patients with end-stage renal disease. Disorders of mineral… (More)
Is this relevant?
2002
2002
BACKGROUND Clinical studies have shown sevelamer HCl (Renagel) to be effective for the reduction of serum phosphate in… (More)
Is this relevant?